Agonistic anti-OX40 monoclonal antibody MEDI6469
Agonistic anti-OX40 monoclonal antibody MEDI6469 Uses, Dosage, Side Effects, Food Interaction and all others data.
Agonistic anti-OX40 monoclonal antibody MEDI6469 is a monoclonal antibody under investigation in clinical trial NCT02205333 (A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies).
| Trade Name | Agonistic anti-OX40 monoclonal antibody MEDI6469 |
| Generic | MEDI-6469 |
| MEDI-6469 Other Names | Agonistic anti-OX40 monoclonal antibody MEDI6469 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Agonistic anti-OX40 monoclonal antibody MEDI6469
